CA2050255A1 - Derives du 1-methylcarbapenem et procede d'obtention - Google Patents

Derives du 1-methylcarbapenem et procede d'obtention

Info

Publication number
CA2050255A1
CA2050255A1 CA2050255A CA2050255A CA2050255A1 CA 2050255 A1 CA2050255 A1 CA 2050255A1 CA 2050255 A CA2050255 A CA 2050255A CA 2050255 A CA2050255 A CA 2050255A CA 2050255 A1 CA2050255 A1 CA 2050255A1
Authority
CA
Canada
Prior art keywords
preparation
hydrogen atom
methylcarbapenem derivatives
methylcarbapenem
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2050255A
Other languages
English (en)
Other versions
CA2050255C (fr
Inventor
Tameo Iwasaki
Kazuhiko Kondo
Hiroshi Horikawa
Totaro Yamaguchi
Tadahiro Matsushita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tameo Iwasaki
Kazuhiko Kondo
Hiroshi Horikawa
Totaro Yamaguchi
Tadahiro Matsushita
Tanabe Seiyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tameo Iwasaki, Kazuhiko Kondo, Hiroshi Horikawa, Totaro Yamaguchi, Tadahiro Matsushita, Tanabe Seiyaku Co., Ltd. filed Critical Tameo Iwasaki
Publication of CA2050255A1 publication Critical patent/CA2050255A1/fr
Application granted granted Critical
Publication of CA2050255C publication Critical patent/CA2050255C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002050255A 1990-09-07 1991-08-29 Derives du 1-methylcarbapenem et procede d'obtention Expired - Fee Related CA2050255C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP238420/1990 1990-09-07
JP23842090 1990-09-07
JP70285/1991 1991-01-14
JP7028591 1991-01-14

Publications (2)

Publication Number Publication Date
CA2050255A1 true CA2050255A1 (fr) 1992-03-08
CA2050255C CA2050255C (fr) 1997-02-04

Family

ID=26411452

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002050255A Expired - Fee Related CA2050255C (fr) 1990-09-07 1991-08-29 Derives du 1-methylcarbapenem et procede d'obtention

Country Status (16)

Country Link
US (1) US5153187A (fr)
EP (1) EP0474243B1 (fr)
JP (1) JPH0745500B2 (fr)
KR (1) KR0148379B1 (fr)
CN (1) CN1033455C (fr)
AT (1) ATE164582T1 (fr)
AU (1) AU630574B2 (fr)
CA (1) CA2050255C (fr)
DE (1) DE69129175T2 (fr)
DK (1) DK0474243T3 (fr)
ES (1) ES2115600T3 (fr)
FI (2) FI95470C (fr)
HU (2) HU211122B (fr)
IE (1) IE913065A1 (fr)
IL (1) IL99399A0 (fr)
SG (1) SG49607A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
JP2569455B2 (ja) * 1992-03-06 1997-01-08 田辺製薬株式会社 β−ラクタム誘導体の製法
EP0937725A3 (fr) 1992-04-28 2004-12-01 Tanabe Seiyaku Co., Ltd. Méthode pour débloquer un groupe hydroxyle protégé
US5587474A (en) * 1992-06-18 1996-12-24 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for carboxyl group
US5442055A (en) * 1992-11-13 1995-08-15 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5631363A (en) * 1992-11-13 1997-05-20 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5495012A (en) * 1992-12-28 1996-02-27 Tanabe Seiyaku Co., Ltd. Process for preparing optically active 4-mercapto-2-pyrrolidone derivative and intermediate therefor
JP2701685B2 (ja) * 1992-12-28 1998-01-21 田辺製薬株式会社 光学活性４−メルカプト−２−ピロリドン誘導体及びその合成中間体の製法
US5750686A (en) * 1993-06-16 1998-05-12 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and process for producing the same
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
AU4596096A (en) * 1994-09-06 1996-03-27 Banyu Pharmaceutical Co., Ltd. Novel carbapenem derivative
JP2969616B2 (ja) 1994-11-24 1999-11-02 田辺製薬株式会社 ４−メルカプトピロリジン化合物の製法
EP0913151B1 (fr) 1996-05-09 2002-09-04 Sankyo Company, Limited Compositions de lutte contre helicobacter pylori contenant des derives de 1-methylcarbapenem en tant qu'ingredient actif
JPH1077285A (ja) 1996-09-04 1998-03-24 Sumitomo Pharmaceut Co Ltd 新規なβ−ラクタム化合物およびその製造法
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
KR100945706B1 (ko) * 2001-11-05 2010-03-05 다이닛본 스미토모 세이야꾸 가부시끼가이샤 신규 카르바페넴 화합물
CA2519794A1 (fr) 2003-04-08 2004-10-21 Sumitomo Pharmaceuticals Co., Ltd. Nouveaux composes de carbapenem
CA2577924A1 (fr) * 2004-09-03 2006-03-09 Dainippon Sumitomo Pharma Co., Ltd. Nouveau derive de carbapeneme
JPWO2006103999A1 (ja) * 2005-03-25 2008-09-04 大日本住友製薬株式会社 新規なカルバペネム化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
IE66711B1 (en) * 1988-04-01 1996-01-24 Sankyo Co 2-(heterocyclylthio) carbapenem derivatives their preparation and their use as antibiotics

Also Published As

Publication number Publication date
HU211122B (en) 1995-10-30
DE69129175T2 (de) 1998-09-03
FI95470B (fi) 1995-10-31
FI914187A0 (fi) 1991-09-05
FI95470C (fi) 1996-02-12
ATE164582T1 (de) 1998-04-15
CN1033455C (zh) 1996-12-04
CA2050255C (fr) 1997-02-04
FI100399B (fi) 1997-11-28
DK0474243T3 (da) 1998-12-07
ES2115600T3 (es) 1998-07-01
EP0474243B1 (fr) 1998-04-01
AU630574B2 (en) 1992-10-29
CN1060093A (zh) 1992-04-08
US5153187A (en) 1992-10-06
IL99399A0 (en) 1992-08-18
JPH0745500B2 (ja) 1995-05-17
DE69129175D1 (de) 1998-05-07
HUT59410A (en) 1992-05-28
FI952101A (fi) 1995-05-03
IE913065A1 (en) 1992-03-11
HU211892A9 (en) 1995-12-28
HU912884D0 (en) 1992-01-28
FI914187A (fi) 1992-03-08
SG49607A1 (en) 1998-06-15
JPH04279588A (ja) 1992-10-05
FI952101A0 (fi) 1995-05-03
AU8347991A (en) 1992-03-12
EP0474243A1 (fr) 1992-03-11
KR0148379B1 (ko) 1998-11-02
KR920006358A (ko) 1992-04-27

Similar Documents

Publication Publication Date Title
AU8347991A (en) 1-methylcarbapenem derivatives and process for preparation thereof
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
AU657106B2 (en) Preparation and use of N-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
HU906360D0 (en) Process for producing quinoline derivatives and pharmaceutical preparatives containing such compounds
AU1171897A (en) 1-methylcarbapenem derivatives
IL86462A0 (en) Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
ES8706144A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
GR3007401T3 (fr)
AU645090B2 (en) Novel N-Benzyl-N-Phenyl and -Phenalkyl-Thioureas
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
GR3007219T3 (fr)
AU1669288A (en) Antidiabetic composition comprising 7-thiaprostaglandin e1 or its derivative
EP0590681A3 (en) A process for the preparation of aminothiadiazolylacetyl halide derivatives
HU910108D0 (en) Process for the production of macrolide compounds
PL264320A1 (en) A fungicide and a method of active matter production
AU3630489A (en) Novel derivatives and processes for the production thereof
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
ATE186907T1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
AU3668289A (en) Novel esters of estramustine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed